Author:
Behre G.,Ostermann H.,Rothenburger M.,Schiel X.,Bockelmann D.,Geiger S.,Dedroogh M.,Helmerking M.,Wörmann B.,Kienast J.,Hiddemann W.
Publisher
Springer Berlin Heidelberg
Reference30 articles.
1. Pizzo PA:Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323–32
2. Ziegler EJ, Fisher CJ, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NNH, Allen IE, Berger HJ, Knatterud GL, LoBuglio AF, Smith CR, the HA-1A sepsis study group. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324: 429–36
3. Deresinski S, De Pauw BE, Feld R. Empirical treatment of Gram-negative bacteremia in granulocytopenic patients with leukemia. Program Abstr 30th Intersci Conf Antimicrob Agents Chemother 1990; abstract 251
4. The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692–8
5. Ostermann H, Rothenburger M, Mesters RM, van de Loo J, Kienast J. Cytokine release during sepsis in leukocytopenic patients: results of a prospective study. Blood 1993; 82 (Suppl 1): abstract 997